Results 61 to 70 of about 18,158,432 (307)

Оценка Т-клеточного иммунитета к SARS-CoV-2 у переболевших и вакцинированных против COVID-19 лиц с помощью ELISPOT набора ТиграТест® SARS-CoV-2 [PDF]

open access: yes, 2021
With the onset of the COVID-19 pandemic, a number of molecular-based tests have been developed to diagnose SARS-CoV-2 infection. However, numerous available serological tests lack sufficient sensitivity or specificity.
Р. А. Хамитов   +11 more
core   +2 more sources

Erythema Multiforme Major following SARS‐CoV‐2 vaccine

open access: yesClinical Case Reports, 2021
Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2.
Alberto Maria Saibene   +7 more
doaj   +1 more source

The heart and SARS-CoV-2

open access: yesMedicina Clínica (English Edition), 2022
SARS-Cov2 is currently causing a persistent Covid-19 pandemic, which poses a risk of causing long-term cardiovascular sequels in the population. The viral mechanism of cell infection through the angiotensin 2 converter enzyme receptor and the limited antiviral innate immune response are the suspected causes for a more frequent cardiovascular damage in ...
González-Calle, David   +2 more
openaire   +3 more sources

Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent Fc gamma R Pathway [PDF]

open access: yes, 2011
Copyright © 2011, American Society for Microbiology. All Rights Reserved.Public health measures successfully contained outbreaks of the severe acute respiratory syndrome coronavirus (SARS-CoV) infection.
Cheung, Chung y   +40 more
core   +1 more source

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV [PDF]

open access: yes, 2020
After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003, human coronaviruses (HCoVs) have been reported as pathogens that cause severe symptoms in respiratory tract infections.
Yunlong Wang   +15 more
core   +1 more source

SARS‐CoV‐2 infection with bilateral intralabyrinthine hemorrhage

open access: yesClinical Case Reports, 2022
A 47‐year‐old woman presented with the complaint of sudden hearing loss associated with vertigo. Serological testing was positive for IgM and negative for IgG COVID‐19 antibodies, with no other associated factors.
Vagner Antonio Rodrigues daSilva   +6 more
doaj   +1 more source

IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection [PDF]

open access: yes, 2021
The renal involvement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported. The etiology of kidney injury appears to be tubular, mainly due to the expression of angiotensin-converting enzyme 2, the key joint receptor for SARS-
Miguel Ángel Solís   +9 more
core   +1 more source

SARS CoV- 2 vaccination induces antibodies against cardiolipin

open access: yesBMC Research Notes, 2022
Objective Cases of thrombosis have been reported after administration of SARS-CoV-2 vaccines, with controversial results relating to Oxford-AstraZeneca’s ChAdOx1-S.
George Krashias   +5 more
doaj   +1 more source

SARS-CoV-2 testing. [PDF]

open access: yes, 2021
SARS-CoV-2 testing.
Mattias Mandorfer (584776)   +9 more
core   +1 more source

SARS‐CoV‐2 Omicron variant: Characteristics and prevention

open access: yesMedComm, 2021
Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in
Xuemei He   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy